Sidley Austin advised PhaseV Trials Inc. on the transaction. PhaseV Trials Inc., a leader in AI/ML-driven clinical development, announced its US$50 million Series A financing round....
Sidley Austin advised PhaseV Trials Inc. on the transaction. PhaseV Trials Inc., a leader in AI/ML-driven clinical development, announced its US$50 million Series A financing round....
